Speakers

Dr. Jolien Duponselle is a PhD Candidate under the supervision of Prof. dr. van Geel at the Ghent University/Ghent university Hospital in Belgium.

Dr. Parsad's research interests include vitiligo pathogenesis and treatment.

Beth Schneider has been a market research professional for over 35 years. She has been at MyHealthTeams for over 5 years, where she has focused on both survey research and social listening analysis. Since joining MyHealthTeams, Beth has conducted research on a variety of conditions including multiple sclerosis, endometriosis, irritable bowel disease, vitiligo, osteoporosis, psoriasis, lupus, narcolepsy, rheumatoid arthritis and more. Her work has been co-presented at a number of conferences including ACOG, AMCP, CMSC, ACG, ACR, LUPUS-CORA and ECTRIMS and she is a co-author of research published in the Journal of Endometriosis and Pelvic Pain Disorders as well as the Journal of Pain Research. Prior to joining MyHealthTeams, Beth led global, corporate, and small business research at a technology company, where she received the founder’s Innovation award for her work on measuring potential new product demand. Beth has a strong background in quantitative and qualitative research. She has spoken at several market research conferences, including the Market Research Event (IIR), and has been featured in Forrester white papers on the state of market research. Beth graduated summa cum laude with a BA in Psychology from San Francisco State University and completed her doctoral coursework in Educational Psychology from Stanford University.

Pursuing Ph.D. and working on understanding vitiligo pathogenesis

Graduated in Chemistry, with the title of Specialist in Biotechnological Applications and a master's degree in Clinical Molecular Diagnostics. The research activity has been focused on projects involving oxidative stress in inflammatory diseases of the skin and pigmentary disorders. The main area of interest is the role of lipid and lipid peroxides in the induction of inflammatory processes; in this context particular attention is devoted to the study of sebaceous and epidermal lipids and the possible correlation between qualitative and quantitative changes of sebum and stratum corneum composition and the onset of skin diseases. Another area of interest is the study of lipid arrangement in cellular membranes and the role that alterations in phospholipid composition play in signal transduction concerning skin diseases.

Dr. Marissa Ceresnie is the Henry W. Lim Photomedicine Clinical Research Fellow within the Department of Dermatology at Henry Ford Hospital in Detroit, Michigan. She is a sub-investigator in multiple clinical trials focusing on pigmentary disorders and multicultural dermatology.

Lecturer of Dermatology, Cairo University Member of Egyptian Vitiligo Group Member of Vitiligo clinic, kasralainy hospitals Special interest in vitiligo and related clinical research

Currently work as a lecturer of Dermatology, Cairo University, member of the vitiligo unit and vitiligo surgery unit in Kasr al Ainy Hospital.

Professor Thompson is a Consultant Clinical Psychologist with over twenty years of experience of working in the NHS. He is currently the Director of the South Wales Clinical Psychology training programme, which trains clinical psychologists in collaboration with Health Boards in South Wales. He is a Professor of Clinical Psychology at Cardiff University and a visiting Professor in Clinical Psychology at the University of Sheffield. Professor Thompson has over 100 peer reviewed publications and book chapters. He has authored several articles specifically focused on psychosocial aspects of vitiligo. He has supported the work of a number of skin and burn care related charities internationally and within the UK, and he is a lead author of the Wiley clinical psychology textbook on working with appearance concern. He was the lead psychological advisor to the UK 2020 All Party Parliamentary Group on Skin Mental Health Report.

Professor of Dermatology at the University Hospital of Nice. He also heads the laboratory INSERM U1065 team 12, C3M, dedicated to the study of molecular mechanisms involved in pigmentation and melanoma. He heads the University laser center in Nice. He is president of the Department of Clinical Research and Innovation of Nice University hospital and vice-president of Côte d’Azur University. He has seven international patents and more than 220 publications in scientific journals (h-index 41). He is co-founder of YUKIN therapeutics. His fields of research includes pigmentary disorders (including vitiligo and melasma), melanoma, hidradenitis suppurativa, alopecia areata and lasers.